Bayer: Barclays lowers its target price

(CercleFinance.com) - While maintaining its 'weighted in line' recommendation on Bayer, Barclays has lowered its price target from €26 to €22, judging in particular that 'investors need more clarity on liquidity for next year'.


Although Bayer has maintained its 2024 outlook for sales and adjusted EPS, cautious comments concerning its three businesses for 2025 (so that a drop in results is expected) makes the configuration more difficult", warns the broker.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.